(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 3.69% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.34%.
Quidelortho's revenue in 2026 is $2,657,200,000.On average, 7 Wall Street analysts forecast QDEL's revenue for 2026 to be $188,411,702,607, with the lowest QDEL revenue forecast at $179,137,728,103, and the highest QDEL revenue forecast at $195,094,419,529. On average, 7 Wall Street analysts forecast QDEL's revenue for 2027 to be $194,889,846,562, with the lowest QDEL revenue forecast at $184,047,479,311, and the highest QDEL revenue forecast at $204,845,730,956.
In 2028, QDEL is forecast to generate $202,118,091,396 in revenue, with the lowest revenue forecast at $190,934,769,200 and the highest revenue forecast at $215,210,761,284.